News

Filter

1 to 9 of 95955 results

FTC puts conditions on acquisition of Insight Pharma by Prestige Brands

29-08-2014

US firm Prestige Brands Holdings, the maker of Dramamine (dimenhydrinate), has agreed to divest assets…

Insight PharmaceuticalsMergers & AcquisitionsPharmaceuticalPrestige BrandsRegulationUSA

Ipsen posts strong earnings growth for first-half 2014

29-08-2014

French drugmaker Ipsen has reported first half 2014 sales of 638.7 million euros ($845.1 million), up…

FinancialIpsenPharmaceutical

FDA approves Elelyso for pediatric use in Gaucher disease

29-08-2014

The US Food and Drug Administration has approved US pharma giant Pfizer’s Elelyso (taliglucerase alfa)…

ElelysoPfizerPharmaceuticalProtalix BioTherapeuticsRare diseasesRegulationUSA

Colorectal cancer market will remain steady at $7.7 billion by 2023; report

29-08-2014

The market for colorectal cancer (CRC) therapies will remain constant, at around $7.7 billion by 2023…

EuropeJapanMarkets & MarketingOncologyPharmaceuticalUSA

Tau Therapeutics and Xdynia merge to form Cavion

29-08-2014

Privately-held US drugmakers Tau Therapeutics and Xdynia announced today that they have merged; the surviving…

CavionMergers & AcquisitionsNeurologicalOncologyPharmaceuticalTau TherapeuticsXdynia

India's Piramal will divert resources from early-stage research to advanced-stage molecules

India's Piramal will divert resources from early-stage research to advanced-stage molecules

29-08-2014

Indian pharma company Piramal Enterprises has announced its intention to stop early-stage research in…

IndiaMetabolic disordersPharmaceuticalPiramal EnterprisesPiramal HealthcareProductionResearchSwati PiramalUS Food and Drug Administration

Minomic to reformulate its MIL-38 prostate cancer screening target as a therapy with Catalent

Minomic to reformulate its MIL-38 prostate cancer screening target as a therapy with Catalent

29-08-2014

Australian biotech company Minomic International will join forces with Catalent Pharma to develop its…

AustraliaBiotechnologyCatalent PharmaMinomicOncologyProstate cancerProstate cancer screening technologyResearch

Takeda's 10-year study finds no link between pioglitazone and bladder cancer

Takeda's 10-year study finds no link between pioglitazone and bladder cancer

29-08-2014

Japan’s largest drugmaker Takeda has completed the post-marketing commitment and data submissions to…

Bladder cancerEuropean Medicines AgencyJapanOncologyPharmaceuticalPioglitazoneRegulationResearchTakeda PharmaceuticalsUS Food and Drug Administration

1 to 9 of 95955 results

Back to top